期刊文献+

烟台地区肺炎链球菌的耐药性检测 被引量:1

Surveillance of antimicrobial resistance of streptococcus pneumoniae in Yantai area
下载PDF
导出
摘要 目的监测烟台地区肺炎链球菌的耐药性,为临床合理应用抗菌药物提供理论依据。方法收集烟台地区部分医院临床分离的肺炎链球菌,用E-试验、K-B法检测此菌对青霉素等10种抗菌药物的敏感度。结果102株肺炎链球菌中71株(70%)对青霉素不敏感。未检出对头孢噻肟、阿莫西林、左旋氧氟沙星和万古霉素耐药的菌株。对克林霉素、红霉素、四环素和复方新诺明耐药率很高,分别为97%、100%、100%和96%。结论烟台地区青霉素不敏感肺炎链球菌检出率高,对大环内酯类药物耐药状况极为严峻。 Objective To monitor the antimicrobial resistance of streptococcus pneumonlae m Yantai area so as to provide theoretical basis for rational use of antibiotics. Methods The clinical streptococcus pneumoniae isolates were collected from some hospitals in Yantai area. E-test and K-B disk diffusion method were used to determine the susceptibility of streptococcus pneumoniae to 10 anti- microbial agents. Results Sevent-one streptococcus pneumoniae isolates(71/102, 70%) were insensi-tive to penicillin. None of cefotaxime-, amoxicillin-, levofloxacin-, and vancomycin-resistant strains was found. The resistance rate of streptococcus "pneumoniae was relatively highly resistant to clindamycin, erythromycin, tetracycline and TMP-SMZ, 97%, 100%, 100% and 96% respectively. Conclusion Penicillin non-susceptible streptococcus pneumoniae is highly prevalent in Yantai area. The situation is serious about macrolide-resistance of streptococcus pneumoniae.
出处 《国际检验医学杂志》 CAS 2009年第2期108-110,共3页 International Journal of Laboratory Medicine
基金 烟台市科技发展计划项目(2005126)
关键词 链球菌 肺炎 青霉素类 大环内酯类 抗药性 细菌 Streptococcus pneumoniae Penicillins Macrolides Drug resistance,Bacterial
  • 相关文献

参考文献12

二级参考文献58

  • 1沈定霞,罗燕萍,崔岩,赵莉萍,白立彦.分离产金属β-内酰胺酶的铜绿假单胞菌[J].中华医院感染学杂志,2004,14(1):86-88. 被引量:109
  • 2林淑珍,田德英,孙自镛.84株肺炎链球菌的耐药性测定[J].中华医院感染学杂志,2004,14(2):226-228. 被引量:10
  • 3[1]Hortal M,Lovegren M,de la Hoz F,et al. Antibiotic resistance in Streptococcus pneumoniae in six Latin American countries:1993-1999 surveillance[J]. Microb Drug Resist, 2001 , 7:391-401
  • 4[2]Song JH . Global crisis of pneumococcal resistance; Alam calls from the East[C]. 3th ISAAR ,2001,54
  • 5[5]Lee CK, Liu JW, Leu HS , et al . Streptococcus pneumoniae bacteremia in southern Taiwan [J]. J Microbiol Immunol Infect ,2002 ,35 :17-22
  • 6[6]Sangthawan P,Chantaratchada S,Chanthadisai N,et al. Prevalence and clinical significance of community-acquired penicillinresistant streptococcus pneumoniae in Thailand[J]. Respirology, 2003,8 :208-212
  • 7[7]National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing [S].M100-S12. 2002 ;22 : 66
  • 8[8]Doern GV, Heilmann KP, Huynh HK, et al. Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000,including a comparison of resistance rates since 1994-1995 [J]. Antimicrob Agents Chemother,2001 45 : 1721-1729
  • 9[9]Boost MV,O'Donoghye MM,Dooley JS. Prevalence of carriage of antimicrobial resistant strains of Streptococcus pneumoniae in primary school children in Hong Kong[J]. Epidemiol Infect,2001,127 : 49-55
  • 10[4]Hirakata Y, Izumikawa K, Yamaguchi K, et al.Rapid detection and evolution of clinical characteristics of emerging multiple-drug-resistant Gram-negative rods carrying the metallo-β-lactamase gene blaIMP[J]. Antimicrob Agents Chemother, 1998, 42: 2006-2011.

共引文献215

同被引文献14

  • 1杨锦红,周义正,刘立雪,李向阳.肺炎链球菌红霉素相关耐药基因与耐药表型的关系[J].中华医院感染学杂志,2007,17(6):643-646. 被引量:10
  • 2叶应妩,王毓三.全国检验操作规程[M].2版.南京:东南大学出版社,1997:267.
  • 3Daneman N, McGeer A,Green K. Macrolide resistance in Bactere- mic pneumococcal disease., implications for patient management [J]. Clin Infect Dis,2006,15(43) :432-438.
  • 4Fuller JD, McGeer A, Low DE. Drug-resistant pneumococcal pneumo- nia: clinical relevance and approach to management[J]. Eur J Clin Microbiol Infect Dis,2005,24(12) :780-788.
  • 5Sutcliffe J, Grebe T, Tait-Kamradt A, et al. Detection of erythro- mycin-resistant determinants by PCR[J]. Antimicrob Agents Che- mother,1996,40(ll) :2562-2566.
  • 6Adam D. Global antibiotic resistance in Streptococcus pneumoniae [J]. J Antimicrob Chemother, 2002,50 : S1-5.
  • 7Felmingham D, Reinert RR, Hirakata Y, et al. Increasing preva- lence of antimicrobial resistance among isolates of Streptococcus pneumoniae from the PROTEKT surveillance study, and compara- tive in vitro activity of the ketolide, telithromycin[J]. J Antimi- crob Chemother, 2002,50(1) : 25-37.
  • 8Song JH,Jung SI,Ko KS,et al. High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in A- sia[J]. Antimicroh Chemother,2004,48(6) :2101-2107.
  • 9Kiyoshi S,Norikazu Y,Tetsuo H. High prevalence of erythromycin resistance and macrolide-resistanee genes, mefA and ermB, in Streptococcus pneumoniae isolates from the upper respiratory tracts of children in the Sapporo district,Japan[J]. J Infect Che- mother,2007,13(4) :219-223.
  • 10Li Y, Tomital H, Lv Y. Molecular characterization of erm(B) and mef(E)-mediatederythromyein-resistant Streptococcus pneumoni ae in China and complete DNA sequence of Tn2010[J]. J Appl Microbiol, 2011,110(1) :254-265.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部